New Data on Subcutaneous Bortezomib

被引：1
|
作者：
Moreau, Philippe [1 ]
Touzeau, Cyrille [1 ]
机构：
[1] Univ Hosp, Dept Hematol, F-44093 Nantes, France
来源：
ACTA HAEMATOLOGICA | 2015年 / 133卷 / 01期
关键词：
RELAPSED MULTIPLE-MYELOMA; INTRAVENOUS BORTEZOMIB; COMBINATION REGIMENS; INJECTION;
D O I：
10.1159/000362639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 28
页数：3
相关论文
共 50 条
  • [1] Subcutaneous Bortezomib In Multiple Myeloma
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (01) : 45 - 54
  • [2] Is Subcutaneous Bortezomib Ready for Prime Time?
    Lonial, Sagar
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (02) : 73 - 74
  • [3] Is Subcutaneous Bortezomib Ready for Prime Time?
    Sagar Lonial
    Current Hematologic Malignancy Reports, 2011, 6 : 73 - 74
  • [4] Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy
    Junya Kuroda
    Shinsuke Mizutani
    Yuji Shimura
    Saori Maegawa
    Hisao Nagoshi
    Yoshiaki Chinen
    Shotaro Tatekawa
    Taku Tsukamoto
    Yoshimi Mizuno
    Mio Yamamoto-Sugitani
    Tsutomu Kobayashi
    Yosuke Matsumoto
    Shigeo Horiike
    Masafumi Taniwaki
    Annals of Hematology, 2015, 94 : 687 - 689
  • [5] Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy
    Kuroda, Junya
    Mizutani, Shinsuke
    Shimura, Yuji
    Maegawa, Saori
    Nagoshi, Hisao
    Chinen, Yoshiaki
    Tatekawa, Shotaro
    Tsukamoto, Taku
    Mizuno, Yoshimi
    Yamamoto-Sugitani, Mio
    Kobayashi, Tsutomu
    Matsumoto, Yosuke
    Horiike, Shigeo
    Taniwaki, Masafumi
    ANNALS OF HEMATOLOGY, 2015, 94 (04) : 687 - 689
  • [6] Physicochemical stability of bortezomib solutions for subcutaneous administration
    Gomez, Angela
    Garcia, Ma Cristina Beneitez
    Barrueco, Nelida
    Lucena-Campillo, Ma Amparo
    Lopez-Lunar, Elena
    Garcia-Diaz, Benito
    Vicario-de-la-Torre, Marta
    Escobar-Rodriguez, Ismael
    Gil-Alegre, Maria Esther
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Nicolau syndrome secondary to subcutaneous Bortezomib injection
    Almudimeegh, A.
    Le Pelletier, F.
    Dupin, N.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (02) : 348 - 350
  • [8] The advantages of switch to subcutaneous bortezomib in the real life
    Mangiacavalli, Silvia
    Cocito, Federica
    Ferretti, Virginia Valeria
    Ganzetti, Maya
    Cartia, Claudio Salvatore
    Corso, Alessandro
    LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1505 - 1507
  • [9] Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib
    Obeid, Karam M.
    Ferrara, Richard
    Sharma, Mamta
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (04): : 284 - 286
  • [10] SUBCUTANEOUS ADMINISTRATION OF BORTEZOMIB REDUCES ADVERSE EVENTS
    Martinez-Losada, C.
    Llamas-Poyato, M.
    Rodriguez-Garcia, G.
    Garzas, C.
    Buenasmananas, D.
    Garcia, E.
    Chic, C.
    Alvarez, M.
    HAEMATOLOGICA, 2013, 98 : 599 - 599
12345